PetMed Express, Inc.
PETS
$1.82
-$0.07-3.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 168.86M | 179.02M | 186.96M | 198.27M | 211.95M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 168.86M | 179.02M | 186.96M | 198.27M | 211.95M |
| Cost of Revenue | 121.71M | 128.81M | 135.49M | 140.12M | 147.44M |
| Gross Profit | 47.15M | 50.22M | 51.47M | 58.15M | 64.50M |
| SG&A Expenses | 65.74M | 69.22M | 80.28M | 77.55M | 76.51M |
| Depreciation & Amortization | 9.25M | 9.39M | 9.03M | 8.22M | 7.60M |
| Other Operating Expenses | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Operating Expenses | 196.70M | 207.41M | 224.81M | 225.89M | 231.55M |
| Operating Income | -27.84M | -28.39M | -37.84M | -27.62M | -19.61M |
| Income Before Tax | -29.35M | -57.36M | -59.18M | -48.88M | -39.44M |
| Income Tax Expenses | -69.00K | -73.00K | 5.69M | 6.15M | 4.74M |
| Earnings from Continuing Operations | -29.28 | -57.29 | -64.87 | -55.02 | -44.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.28M | -57.29M | -64.87M | -55.02M | -44.18M |
| EBIT | -27.84M | -28.39M | -37.84M | -27.62M | -19.61M |
| EBITDA | -18.59M | -19.00M | -28.81M | -19.40M | -12.00M |
| EPS Basic | -1.39 | -2.75 | -3.12 | -2.65 | -2.13 |
| Normalized Basic EPS | -0.78 | -0.81 | -1.14 | -0.83 | -0.57 |
| EPS Diluted | -1.39 | -2.76 | -3.13 | -2.66 | -2.14 |
| Normalized Diluted EPS | -0.78 | -0.81 | -1.14 | -0.83 | -0.57 |
| Average Basic Shares Outstanding | 84.61M | 83.69M | 83.29M | 82.92M | 82.63M |
| Average Diluted Shares Outstanding | 84.61M | 83.69M | 83.29M | 82.92M | 82.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.08% | -0.04% | -0.04% | -0.05% | -0.18% |